Key facts
- This page summarizes Tracey L. McCain's Form 4 filing for Kiniksa Pharmaceuticals, Ltd. (KNSA).
- 4 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 07 Jun 2024, 16:37.
Tracey L. McCain - 05 Jun 2024 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)
- Reporting relationship
- Director
- Issuer ticker
- KNSA
- Reported as of
- 05 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Jun 2024, 16:37:53 UTC
- Prior SEC filing
- 11 Mar 2024
- Next SEC filing
- 04 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Madelyn Zeylikman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Tracey L. McCain filed Form 4 for Kiniksa Pharmaceuticals, Ltd. (KNSA) on 07 Jun 2024.
Change
- Previous filing in this sequence was filed on 11 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KNSA
transaction
Class A Common Share
Options Exercise
- Transaction value
- Shares
- +4,373
- Change %
- +87%
- Price
- Shares after
- 9,373
- Date
- 06 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KNSA
transaction
Derivative
Share Option
Award
- Transaction value
- $0
- Shares
- +19,040
- Change %
- Price
- $0.000000
- Shares after
- 19,040
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Class A Common Shares
- Underlying amount
- 19,040
- Exercise price
- $19.71
- Footnotes
- F2
KNSA
transaction
Derivative
Restricted Share Units
Award
- Transaction value
- $0
- Shares
- +3,173
- Change %
- Price
- $0.000000
- Shares after
- 3,173
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Class A Common Shares
- Underlying amount
- 3,173
- Exercise price
- Footnotes
- F1, F3
KNSA
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,373
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 06 Jun 2024
- Ownership
- Direct
- Underlying class
- Class A Common Shares
- Underlying amount
- 4,373
- Exercise price
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
Footnote F2
The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 5, 2024.
Footnote F3
The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024.
Footnote F4
The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs.